Inactive Instrument

Neovasc Inc.

Equities

NVCN

CA64065J4037

Advanced Medical Equipment & Technology

Neovasc Inc. Appoints Vicki Bebeau in the Role of Vice President, Clinical Affairs

May 08, 2014 at 12:00 pm

Neovasc Inc. announced that Vicki Bebeau has joined the company in the role of Vice President, Clinical Affairs, a newly-created position. Ms. Bebeau brings Neovasc more than 18 years of experience in clinical trial planning and management at industry leaders St. Jude Medical, Boston Scientific and Medtronic.

Latest news about Neovasc Inc.

Shockwave Medical Completes Acquisition of Neovasc	11/04/23	MT
ShockWave Medical Closes Neovasc Acquisition; Shares Rise	11/04/23	MT
Traders Cautious as Inflation Data, Fed Minutes Loom, Stifling US Equity Futures	11/04/23	MT
Neovasc Inc.(NasdaqCM:NVCN) dropped from NASDAQ Composite Index	11/04/23	CI
ShockWave Medical, Inc. completed the acquisition of Neovasc Inc. from Strul Medical Group LLC and others.	10/04/23	CI
Neovasc Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	31/03/23	CI
Neovasc 2022 Loss Widens Ahead of Sale to Shockwave Medical	31/03/23	MT
Neovasc Inc. Auditor Raises 'Going Concern' Doubt	30/03/23	CI
Neovasc Shareholders Approve Proposed Takeover by Shockwave Medical	07/03/23	MT
Neovasc Announced German Reimbursement Renewal	01/02/23	MT
HC Wainwright Downgrades Neovasc to Neutral From Buy	18/01/23	MT
Top Midday Gainers	17/01/23	MT
ShockWave Medical to Acquire Neovasc in Initial $100 Million Deal; Neovasc Shares Jump	17/01/23	MT
Shockwave Medical In Agreement to Acquire Neovasc	17/01/23	MT
Transcript : Neovasc Inc., ShockWave Medical, Inc. - M&A Call	17/01/23
Neovasc Brief: Neovasc shareholders will also receive a potential deferred payment in form of a non-tradable contingent value right entitling holder to receive up to an additional US$12 per share in cash if certain regulatory milestones are achieved	17/01/23	MT
Neovasc Brief: Shockwave Medical will acquire all outstanding Neovasc shares for an upfront cash payment of US$27.25 per share, corresponding to an enterprise value of approximately $100 million, inclusive of certain deal-related costs	17/01/23	MT
Neovasc Brief: Shockwave Medical Announcing Agreement to Acquire Neovasc	17/01/23	MT
ShockWave Medical, Inc. entered into a definitive agreement to acquire Neovasc Inc. from Strul Medical Group LLC and others for $75 million.	16/01/23	CI
Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday	29/11/22	MT
MT Newswires Canada Overnight Stocks To Watch: Organigram; MEG Energy; Neovasc Inc	29/11/22	MT
Neovasc Plans to Randomize 380 Patients in Reducer Trial	28/11/22	MT
Neovasc Announces Progress on COSIRA-II Clinical Trial	28/11/22	CI
Neovasc Reducer UK Case Study Published in European Heart Journal	18/11/22	MT
Transcript : Neovasc Inc., Q3 2022 Earnings Call, Nov 10, 2022	10/11/22

Chart Neovasc Inc.

Duration

Period

More charts

Company Profile

Neovasc Inc. is a Canada-based specialty medical device company. The Company develops, manufactures, and markets products for the cardiovascular marketplace. The Company is engaged in the development of minimally invasive therapies in cardiovascular care: refractory angina and mitral valve regurgitation. Its products include the Neovasc Reducer (Reducer), for the treatment of refractory angina, and the Tiara (Tiara), for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States, Canada, Israel and Europe. The Company operates through one business segment: the development, manufacturing and marketing of medical devices. The Company's subsidiaries include Neovasc Medical Inc., Neovasc Tiara Inc., Neovasc (US) Inc., Neovasc Medical Ltd., B-Balloon Ltd., Neovasc GmbH, and Neovasc Management Inc. The Company carries its business in Canada, the United States and Europe.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+10.22%	223B
DANAHER CORPORATION	+12.99%	194B
INTUITIVE SURGICAL, INC.	+18.09%	141B
BOSTON SCIENTIFIC CORPORATION	+28.66%	109B
SIEMENS HEALTHINEERS AG	+2.09%	64.85B
EDWARDS LIFESCIENCES CORPORATION	+14.70%	52.7B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+6.68%	51.77B
AGILENT TECHNOLOGIES, INC.	+8.29%	44.12B
GE HEALTHCARE TECHNOLOGIES INC.	+2.60%	36.21B

Other Advanced Medical Equipment & Technology